RedShiftBio Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series F
- Latest Deal Amount
-
$5.91M
- Investors
-
5
RedShiftBio General Information
Description
Developer of bioanalytical instrumentation designed to transform protein characterization. The company's tools combine laser, microfluidics, and analytical technologies for the development of protein therapeutic drugs, as well as the measurement of protein-based drug therapies, enabling scientists to detect and monitor protein conformation and conduct label-free protein analysis.
Contact Information
Website
www.redshiftbio.comCorporate Office
- 80 Central Street
- Boxborough, MA 01719
- United States
Corporate Office
- 80 Central Street
- Boxborough, MA 01719
- United States
RedShiftBio Timeline
RedShiftBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC (Series F) | 25-Jun-2025 | $5.91M | Completed | Generating Revenue | ||
| 13. Debt - General | 24-Jul-2024 | Completed | Generating Revenue | |||
| 12. Later Stage VC (Series E) | 21-Mar-2024 | Completed | Generating Revenue | |||
| 11. Mezzanine | 23-Mar-2022 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | 01-May-2021 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D) | 23-Dec-2020 | Completed | Generating Revenue | |||
| 8. Debt - PPP | 12-Apr-2020 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Private | 01-Jul-2018 | Completed | Startup | |||
| 6. Later Stage VC (Series C) | 08-Mar-2017 | $10.8M | $38.8M | Completed | Startup | |
| 5. Later Stage VC (Series B) | 02-Oct-2015 | $4.75M | $28M | Completed | Startup |
RedShiftBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 52,729,331 | $0.001000 | 8% | $0.18 | $0.18 | 1x | $0.18 | 12.61% |
| Series A1 | 10,401,838 | $0.001000 | 8% | $0.31 | $0.31 | 1x | $0.31 | 2.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
RedShiftBio Comparisons
Industry
Financing
Details
RedShiftBio Competitors (18)
One of RedShiftBio’s 18 competitors is Sphere Fluidics, a Formerly VC-backed company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sphere Fluidics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Biognosys | Formerly VC-backed | Zurich, Switzerland | ||||
| Nanion Technologies | Accelerator/Incubator Backed | Munich, Germany | ||||
| Preomics | Venture Capital-Backed | Munich, Germany | ||||
| MOBILion Systems | Formerly VC-backed | Chadds Ford, PA |
RedShiftBio Patents
RedShiftBio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260140051-A1 | Infrared transmission flow cell with thermal ramping capability | Pending | 18-Nov-2024 | ||
| WO-2026107480-A1 | Infrared transmission flow cell with thermal ramping capability | Pending | 18-Nov-2024 | ||
| US-20250264406-A1 | Infrared transmission cell with attached flow sensor for microfluidic modulation spectroscopy | Pending | 21-Feb-2024 | ||
| WO-2025179173-A1 | Infrared transmission cell with attached flow sensor for microfluidic modulation spectroscopy | Pending | 21-Feb-2024 | ||
| EP-4710092-A1 | Matched optical filter | Pending | 12-May-2023 | G01N21/3577 |
RedShiftBio Signals
RedShiftBio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Illumina Ventures | Venture Capital | Minority | ||
| Hercules Capital (San Mateo) | Lender/Debt Provider | Minority | ||
| Angel (individual) | Minority | |||
| Waters | Corporation | Minority | ||
| Technology Venture Partners (US) | Venture Capital | Minority |
RedShiftBio FAQs
-
When was RedShiftBio founded?
RedShiftBio was founded in 2005.
-
Where is RedShiftBio headquartered?
RedShiftBio is headquartered in Boxborough, MA.
-
What is the size of RedShiftBio?
RedShiftBio has 27 total employees.
-
What industry is RedShiftBio in?
RedShiftBio’s primary industry is Discovery Tools (Healthcare).
-
Is RedShiftBio a private or public company?
RedShiftBio is a Private company.
-
What is the current valuation of RedShiftBio?
The current valuation of RedShiftBio is .
-
What is RedShiftBio’s current revenue?
The current revenue for RedShiftBio is .
-
How much funding has RedShiftBio raised over time?
RedShiftBio has raised $101M.
-
Who are RedShiftBio’s investors?
Illumina Ventures, Hercules Capital (San Mateo), , Waters, and Technology Venture Partners (US) have invested in RedShiftBio.
-
Who are RedShiftBio’s competitors?
Sphere Fluidics, Biognosys, Nanion Technologies, Preomics, and MOBILion Systems are some of the 18 competitors of RedShiftBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process